ACHV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ACHV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Achieve Life Sciences's Average Total Inventories for the three months ended in Sep. 2024 was $0.00 Mil. Achieve Life Sciences's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.00 Mil.
The historical rank and industry rank for Achieve Life Sciences's Days Inventory or its related term are showing as below:
Achieve Life Sciences's Days Inventory stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
The historical data trend for Achieve Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
Achieve Life Sciences Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Achieve Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Achieve Life Sciences's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Achieve Life Sciences's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 |
= | 0 | / | 0 | * | 365 | ||||
= | N/A |
Achieve Life Sciences's Days Inventory for the quarter that ended in Sep. 2024 is calculated as:
Days Inventory (Q: Sep. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2024 ) | + | Total Inventories (Q: Sep. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2024 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 0 | * | 365 / 4 |
= | 0 | / | 0 | * | 365 / 4 | ||||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences (NAS:ACHV) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Achieve Life Sciences's Inventory Turnover for the three months ended in Sep. 2024 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Achieve Life Sciences's Inventory to Revenue for the three months ended in Sep. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 0 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Achieve Life Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard Alistair Stewart | director, officer: President & CEO | 19820 NORTH CREEK PARKWAY, SUITE 201, BOTHELL WA 98011 |
John Bencich | officer: CFO and PFO | 2401 FOURTH AVENUE, SUITE 1050, SEATTLE WA 98121 |
Stuart Duty | director | 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021 |
Thomas Sellig | director | 22722 29TH DR SE, SUITE 100, BOTHELL WA 98021 |
Thomas Braxton King | director | 91 JAMES AVENUE, ATHERTON CA 94027 |
Dialectic Life Sciences Spv Llc | 10 percent owner | C/O DIALECTIC LS MANAGER LLC, 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853 |
Dialectic Ls Manager Llc | 10 percent owner | 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853 |
John Fichthorn | 10 percent owner | C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004 |
Dialectic Capital Management, Lp | 10 percent owner | 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853 |
Dialectic Partners, Llc | 10 percent owner | 2ND FLOOR 119 ROWAYTON AVE, NORWALK CT 06853 |
Vaughn B Himes | director | C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021 |
Financial Group Svb | 10 percent owner | 2270 SAND HILL ROAD, MENLO PARK CA 94025 |
Svb Innovation Credit Partners Viii, Llc | 10 percent owner | 2770 SAND HILL ROAD, MENLO CITY CA 94025 |
Svb Innovation Credit Fund Viii, L.p. | 10 percent owner | C/O SVB INNOVATION CREDIT PARTNERS VIII, 2770 SAND HILL ROAD, MENLO PARK CA 94025 |
Innovation Credit Fund Viii-a, L.p. | 10 percent owner | 2770 SAND HILL ROAD, MENLO PARK CA 94025 |
From GuruFocus
By Marketwired • 10-10-2024
By Marketwired • 07-09-2024
By Marketwired • 07-29-2024
By Marketwired • 05-06-2024
By GuruFocus News • 11-08-2024
By GuruFocus Research • 03-29-2024
By Marketwired • 07-31-2024
By Marketwired • 11-07-2024
By GuruFocus News • 11-08-2024
By GuruFocus Research • 08-15-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.